CLINICAL_TRIALS
trial_result
· 2017-07-18
Clinical Trial Update: A Study of GW856553X For the Treatment of Depression [Phase 2]
Summary
A Phase 2 clinical trial of GW856553X for major depressive disorder was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 2 | Status: TERMINATED